Patients with type-2 diabetes mellitus have an higher risk developing secondary disorders. In an epidemiological longitudinal study of about 1.150 patients with type 2 diabetes mellitus we investigate determinants and predictors for long-term prognosis. The patients are recruited and supervised in practices of general practitioners of the administrative district of Ludwigsburg/Heilbronn (Baden-Württemberg, Germany). In a subgroup of about 200 patients with a dissatisfactory metabolic status (HbA1c \> 7,5%) a randomised interventional study is performed. The intervention comprises a telephone counseling by the medical secretary of each practice executed in a predefined period of time. The outcome parameters of interest are the change of HbA1c, the development of secondary disorders and adverse events, quality of life and risk factor control, as well as hospitalization and mortality. The aim of the study was to develop an patient-centred instrument implementable in the routine medical care in order to enhance the prognosis of patients with type-2 diabetes mellitus.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
204
Telephone counseling is provided once a month by the medical secretary of the general practitioner's practices
Christoph Lücke, MD
Beilstein, Baden-Wurttemberg, Germany
Andrea Walliser-Klöpfer, MD
Benningen am Neckar, Baden-Wurttemberg, Germany
Nader Heydari, MD
Fellbach, Baden-Wurttemberg, Germany
Adelheid Halttunen, MD
Gemmingen, Baden-Wurttemberg, Germany
Hans-Joachim Essich, MD
Heilbronn, Baden-Wurttemberg, Germany
HbA1c
Time frame: 18 months
hospitalization
Time frame: 18 month
CHD, mortality
Time frame: 18 months
lipid metabolism control
Time frame: 18 months
risk factor control (eg. body weight, physical activity, smoking)
Time frame: 18 months
health-related quality of life
Time frame: 18 months
incidence of diabetes-related complications
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Jürgen Wollweber, MD
Heilbronn, Baden-Wurttemberg, Germany
Volker Naser, MD
Heilbronn, Baden-Wurttemberg, Germany
Andreas Wößner, MD
Heilbronn, Baden-Wurttemberg, Germany
Ullrich Barthelmes, MD
Heilbronn, Baden-Wurttemberg, Germany
Axel Möller, MD
Heilbronn, Baden-Wurttemberg, Germany
...and 27 more locations